BONEFROG FOUNDATION
FOUNDED BY VETS 4 VETS
We have witnessed the power that psychedelics have on treating Traumatic Brain Injuries (TBIs). The Bonefrog Foundation was formed with a simple goal in mind – to destigmatize the medicinal use of psychedelic mushrooms and declassify psilocybin as a Schedule 1 Drug. Through awareness, education, scientific research, and the push for universal legislation, we want to be part of the solution that will allow more accurate and effective treatments for those with neurological disorders.
Not All Wounds Are Visible
TRAUMATIC BRAIN INJURIES (TBI) WERE REPORTED FROM VETERANS WHO RETURNED HOME
VETERANS DIE BY SUICIDE EACH DAY
VETERANS WHO USE VA FOR THEIR HEALTHCARE HAVE BEEN DIAGNOSED WITH AT LEAST ONE TBI
UNKNOWN
THE NUMBER OF UNREPORTED AND UNTREATED VETERANS SUFFERING FROM TBI
Delivering Real Solutions
The Bonefrog Foundation is a team of social impact entrepreneurs and special operations combat veterans who are intimately aware of how TBI and other mental health issues are affecting our community. All equally dissatisfied with the current treatment methodologies, our foundation was designed to introduce and analyze the effects of certain natural compounds in treating TBI to deliver real solutions.
Leading Our Research
Dr. Ken Hughes
The research will be led by Dr. Kenneth Hughes PhD. Dr. Hughes is a Chemistry and Biochemistry expert as demonstrated by his work as a professor at the Georgia Institute of Technology for these subjects. Dr. Hughes is a business and technical specialist with broad experience translating complex chemical and biological technologies into Industrial, Consumer and Military commercial products, and builds businesses around these products and technologies.
Benjamin Johnson
Upon retiring from a decade of active-duty as a Navy SEAL operator, Benjamin Johnson immediately became completely enveloped in the “non-standard regenerative healing practices” field building on his medical training and his continued passion for living in service to others. Ben conducts research and gathers data while simultaneously navigating the nuanced legal atmosphere surrounding government-sanctioned frontier biopharmaceutical studies as a founder of Bonefrog Labs.